WILLIAM E. ROTE

CIK 1698262 · Chief Research Officer · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.15M

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$5.22M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVTX Chief Research Officer 118,237 $52.04 $6.15M -$4.65M 28 2026-05-06
Travere Therapeutics, Inc. (RTRX) Delisted Senior Vice President, R&D 24,086 -$567.0K 19 2020-11-17

Recent Filings · Page 5 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-02-13 Travere Therapeutics, Inc. (RTRX) Delisted Sell (S) −1,985 -$42.6K EDGAR
2018-11-16 Travere Therapeutics, Inc. (RTRX) Delisted Sell (S) −5,000 -$120.1K EDGAR
2018-11-14 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +5,000 $0 EDGAR
2018-05-14 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +6,500 $0 EDGAR
2018-02-16 Travere Therapeutics, Inc. (RTRX) Delisted Sell (S) −1,034 -$22.2K EDGAR
2018-02-12 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +1,985 $0 EDGAR
2017-02-15 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +10,000 $0 EDGAR
Showing 4147 of 47
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.